Quoin Pharmaceuticals Ltd. (QNRX)
6.93
-0.04
(-0.57%)
USD |
NASDAQ |
Sep 10, 15:23
Quoin Pharmaceuticals Shareholders Equity (Quarterly) : 3.933M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.933M |
| March 31, 2026 | 8.773M |
| December 31, 2025 | 13.12M |
| September 30, 2025 | -1.215M |
| June 30, 2025 | 2.551M |
| March 31, 2025 | 5.926M |
| December 31, 2024 | 9.205M |
| September 30, 2024 | 5.442M |
| June 30, 2024 | 7.478M |
| March 31, 2024 | 9.126M |
| December 31, 2023 | 5.664M |
| September 30, 2023 | 7.414M |
| June 30, 2023 | 9.072M |
| March 31, 2023 | 10.91M |
| December 31, 2022 | 7.407M |
| September 30, 2022 | 9.168M |
| June 30, 2022 | -3.168M |
| March 31, 2022 | -0.7294M |
| December 31, 2021 | 0.657M |
| September 30, 2021 | -16.25M |
| June 30, 2021 | 1.756M |
| March 31, 2021 | -10.51M |
| December 31, 2020 | -6.607M |
| September 30, 2020 | 5.790M |
| June 30, 2020 | 6.296M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.180M |
| December 31, 2019 | 4.296M |
| September 30, 2019 | 5.313M |
| June 30, 2019 | 6.143M |
| March 31, 2019 | 6.058M |
| December 31, 2018 | 3.726M |
| September 30, 2018 | 4.506M |
| June 30, 2018 | 6.042M |
| March 31, 2018 | 7.739M |
| December 31, 2017 | 5.430M |
| September 30, 2017 | 5.902M |
| June 30, 2017 | 4.282M |
| March 31, 2017 | 4.827M |
| December 31, 2016 | 7.402M |
| September 30, 2016 | 8.503M |
| June 30, 2016 | 3.338M |
| March 31, 2016 | 3.972M |
| December 31, 2015 | 2.699M |
| September 30, 2015 | 3.476M |
| June 30, 2015 | 4.221M |
| March 31, 2015 | 2.873M |
| December 31, 2014 | 3.330M |
| September 30, 2014 | 3.906M |
| June 30, 2014 | 4.573M |
| March 31, 2014 | 0.7366M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.97M |
| Total Liabilities (Quarterly) | 8.037M |
| Current Ratio | 1.760 |